|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS: | |||||||||
| Cash and cash equivalents | |||||||||
| Restricted cash | |||||||||
| Prepaid expenses | |||||||||
| Other current assets | |||||||||
| TOTAL CURRENT ASSETS | |||||||||
| NON-CURRENT ASSETS: | |||||||||
| Restricted cash | |||||||||
| Long-term deposit and other non-current assets | |||||||||
| Property and equipment, net | |||||||||
| Operating lease right-of-use asset | |||||||||
| TOTAL NON-CURRENT ASSETS | |||||||||
| TOTAL ASSETS | |||||||||
| CURRENT LIABILITIES: | |||||||||
| Trade payables | |||||||||
| Current maturities of operating lease liability | |||||||||
| Warrants to preferred shares (including $0 and $186 due to related party, as of December 31, 2024 and December 31, 2023, respectively) | |||||||||
| Employee related obligations | |||||||||
| Other accounts payable | |||||||||
| Other account payable | |||||||||
| Private warrants to purchase ordinary shares (including $* due to related party, as of June 30, 2026 and December 31, 2025) | |||||||||
| Underwriters Promissory Note | |||||||||
| Related Party Promissory Note | |||||||||
| TOTAL CURRENT LIABILITIES | |||||||||
| NON-CURRENT LIABILITIES: | |||||||||
| Long-term operating lease liability | |||||||||
| Underwriters Promissory Note | |||||||||
| Related Party Promissory Note | |||||||||
| TOTAL NON-CURRENT LIABILITIES | |||||||||
| TOTAL LIABILITIES | |||||||||
| TOTAL REDEEMABLE CONVERTIBLE PREFERRED SHARES | |||||||||
| CONTINGENTLY REDEEMABLE NON-CONTROLLING INTERESTS | |||||||||
| TOTAL REDEEMABLE CONVERTIBLE PREFERRED SHARES AND CONTINGENTLY REDEEMABLE NON-CONTROLLING INTERESTS | |||||||||
| SHAREHOLDERS' EQUITY: | |||||||||
| Ordinary shares ($0.135 par value per share, 5,900,000 and 900,000 shares authorized as of June 30, 2026 and December 31, 2025, respectively; 1,179,844 and 312,665 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively) | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| TOTAL SHAREHOLDERS' EQUITY | |||||||||
| TOTAL REDEEMABLE CONVERTIBLE PREFERRED SHARES AND CONTINGENTLY REDEEMABLE NON-CONTROLLING INTERESTS, NET OF CAPITAL DEFICIENCY | |||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |
Loading...
